AN
Alto Neuroscience, Inc.
ANRO · NYSE
$35.80 +0.70% (+$0.25)
1M +26.58%
Market Cap $1.26B
P/E Ratio -
Div. Yield -
ROE 46.46%
Piotroski F-Score Weak
2/9Valuation
28 /100
Expensive P/B 5.73x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
37 /100
Average ROA 33.16%
ROIC 18.43%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -36.26x
Debt/Equity 0.03x
Current ratio 14.85x
Stability
44 /100
Moderate Profitable years 0
Beta 1.09x
EPS volatility 49.23%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ANRO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amit Etkin
Employees
68
Headquarters
Mountain View
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report